Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Innovation·Defining the Future: JETOUR JMA Global Media Alliance Tech Tour Kicks Off
-
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
-
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
CECOCECO Brings First Curved ArtMorph Installation to Workspace Design Show Amsterdam 2025
-
Appian and IFC partner to launch new US$1 billion critical minerals and metals fund for emerging markets
-
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
-
Acies Bio doubling biomanufacturing capacity with the construction of 30 m³ bioreactor
-
SiriusPoint Announces Will Nihan as IMG CEO
-
Consensus estimates ahead of Q3 2025
-
Siili Solutions Plc Financial calendar and annual general meeting 2026
-
Municipality Finance issues SEK 1.5 billion tap under its MTN programme
-
St. Mary Capital Begins Formal IPO Preparations Ahead of Anticipated 2026 Listing
-
MEXC Launches SOL Launchpad: New Users Can Subscribe at 50% Off to Share 465 SOL
-
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
-
Cabka delivers stable Q3 performance in challenging markets and reaffirms focus on profitable growth
-
Siili Solutions Plc, Business review, 1 January–30 September 2025 (unaudited)
-
Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers
-
Equinor ASA: Share buy-back – third tranche for 2025
-
NBPE - Transaction in Own Shares
-
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical On
-
Notice to holders of Icelandic Depository Receipts Simplification and streamlining of Amaroq’s securities under a single ISIN
-
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
-
Caledonia Mining Corporation Plc Third Quarter Production at Blanket Mine
-
Singapore’s largest industrial district cooling system begins operations to support STMicroelectronics’ decarbonization strategy
-
Volta Finance Limited Annual Financial Report and Notice of Annual General Meeting
-
Diamond Update
-
OSB GROUP PLC - Transaction in Own Shares
-
Transaction in Own Shares
-
-
Progress on share buyback programme
-
Elis: Disclosure of trading in own shares occured from October 13 to October 14, 2025
-
Expert Electrician John Bailey Breaks Down California’s Electrical Code & EV Charging Standards for HelloNation
-
Autism Specialist Veronica Glickman of Geneva, IL, Shares the Benefits of Individualized ABA Therapy in HelloNation
-
Roofing Expert Corey Toppin of Richmond, VA, Explains Common Mistakes When Replacing a Roof for HelloNation
-
Education Expert Kim Dunbar of Columbia, South Carolina, Explains What Most People Don’t Realize About Online High School for HelloNation
-
Interim report: January – September 2025
-
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation
-
Jeff Kaulbars Corp Launches “Build With Purpose” Consulting Agency to Empower Latino Entrepreneurs Across the U.S.
-
Sampo plc’s share buybacks 20 October 2025
-
Phonak’s AI revolution continues: new Infinio Ultra hearing aids with clearer sound and easier maintenance
-
OVHcloud - FY25 Results
-
OVHcloud changes its governance structure by reuniting the roles of Chairman of the Board and Chief Executive Officer. Octave Klaba is appointed Chairman of the Board and Chief Executive Officer.
-
Hexagon Purus ASA: Results for the third quarter 2025
-
LHV Group’s unaudited financial results for Q3 and nine months of 2025
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Start of Day Message
-
VALLOUREC SHOWCASES THE LATEST INNOVATIONS OF ITS VAM® CONNECTION AT ADIPEC 2025
-
CREATING POSITIVE IMPACT IN SUSTAINABILITY
-
eQ Plc interim report 1 January - 30 September 2025
